We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Real Time PCR Assays Compared for Viral Quantification

By LabMedica International staff writers
Posted on 14 Jan 2013
The performance of three real time polymerase chain reaction assays has been compared for the quantification of polyomavirus BK.

Reactivation of latent polyomavirus BK is associated with nephropathy (PVAN) after renal transplantation and the BK viral load determinations are a highly sensitive and specific method for predicting risk for PVAN.

At the Albany Medical Center Hospital (NY, USA) a team of investigators collected 100 anticoagulated plasma specimens from 69 renal transplant patients which were analyzed with three real-time PCR (rt-PCR) assays for BK viral load determination. More...
The rt-PCR assays were evaluated in terms of linearity, dynamic range, and accuracy, against a conventional PCR with primers and probe targeting the large T antigen (TOR) (Integrated DNA Technologies, Coralville, IA, USA).

The two commercial rt-PCR assays used were the MultiCode-RTx BK (MC-RTx) virus Analyte Specific Reagents (ASR) from Luminex (Austin, TX, USA), and the MGB-Alert BKV ASR (MGB) from Epoch Biosciences (Princeton, NJ, USA). A laboratory developed assay (LDA) was also evaluated. Of the 100 specimens from 69 patients sent to the laboratory for routine polyomavirus measurements by the TOR and analyzed with all three rt-PCR assays, 76 were defined as true positive for BKV DNA and no samples were inhibitory for PCR.

The MC-RTx assay was positive for all 76 specimens whereas MGB was positive for 64 and LDA was positive for 55. The viral load range for these samples was from1.71 to 7.55 log10 copies/mL, while the median viral load was 3.01 log10 copies/mL. BKV DNA was not detected by any method in the true negative specimens. The sensitivities of the assays was 100% for MC-RTx, 84% for MGB and 72% for LDA and the specificities were 100% for all three assays.

The authors concluded that all three real-time PCR assays are reliable for measuring BKV loads for the identification of patients at risk for PVAN. These assays demonstrated superiority over the TOR with regards to precision. MC-RTx appears to have enhanced sensitivity and better performance among divergent strains of BK. The study was published on December 27, 2012, in the Journal of Clinical Virology.

Related Links:

Albany Medical Center Hospital
Integrated DNA Technologies
Luminex




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.